EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage

Max Ak Rätze, Lotte Nfl Enserink, Noboru Ishiyama, Sven van Kempen, Christina Hj Veltman, Isaac J Nijman, Wisse E Haakma, Carlos Caldas, René Bernards iD, Paul J van Diest iD, Matthias Christgen iD, Thijs Koorman iD and 1 more

The Journal of Pathology · 2025

DOI: 10.1002/path.6394 ↗

At a glance

Journal article in The Journal of Pathology, 2025. Written by Max Ak Rätze and 12 co-authors. Institution: Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. Major MEDLINE topics: Cadherins, Breast Neoplasms, Actins, Microfilament Proteins. Cited 10 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Cooperation in Science and Technology, Horizon 2020 Framework Programme, KWF Kankerbestrijding.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Afadin is a multimodal scaffolding protein with essential functions in cell–cell adhesion. Although its loss of expression has been linked to breast cancer invasion and metastasis, the underlying mechanisms driving tumour progression upon mutational Afadin ( AFDN ) loss in breast cancers remains unclear. In the current study we identified a somatic frameshift AFDN mutation ( p .Lys630fs) in an invasive breast cancer sample that coincides with loss of Afadin protein expression. Functional studies in E‐cadherin‐expressing breast cancer cells show that Afadin loss leads to immature and aberrant adherens junction (AJ) formation. The lack of AJ maturation results in a noncohesive cellular phenotype accompanied by Actomyosin‐dependent anoikis resistance, which are classical progression hallmarks of single‐cell breast cancer invasion. Reconstitution experiments using Afadin truncates show that proper F‐actin organisation and epithelial cell–cell adhesion critically depend on the Coiled‐Coil domain of Afadin but not on the designated C‐terminal F‐actin binding domain. Mouse xenograft experiments based on cell lines and primary patient‐derived breast cancer organoids demonstrate that Afadin loss induces single‐cell lobular‐type invasion phenotypes and overt dissemination to the lungs and the peritoneum. In short, Afadin is a metastasis suppressor for breast cancer through stabilisation and maturation of a mechanical E‐cadherin to F‐actin outside‐in link. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

CadherinsBreast NeoplasmsActinsMicrofilament ProteinsAntigens, CDHumansFemaleAnimalsAdherens JunctionsCell AdhesionMiceCell Line, TumorNeoplasm InvasivenessNeoplasm MetastasisAnoikisMutation

Author keywords

AfadinE‐cadherinadherens junctionmetastatic breast cancer

Substances

CadherinsafadinActinsMicrofilament ProteinsCDH1 protein, humanAntigens, CD

Authors and institutions

  • Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Launchpad Therapeutics, Inc, Cambridge, MA, USA.
  • Center for Molecular Medicine, Cancer Genomics Netherlands, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Department of Oncology, University of Cambridge, Cambridge, UK.
  • Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

ORCID profiles: René Bernards, Paul J van Diest, Matthias Christgen, Thijs Koorman, Patrick Wb Derksen

Funding

  • European Cooperation in Science and Technology
  • Horizon 2020 Framework Programme
  • KWF Kankerbestrijding
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Breast Cancer Now

Cite

APA

Rätze, M. A., Enserink, L. N., Ishiyama, N., van Kempen, S., Veltman, C. H., Nijman, I. J., Haakma, W. E., Caldas, C., Bernards, R., van Diest, P. J., Christgen, M., Koorman, T., & Derksen, P. W. (2025). Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage. The Journal of Pathology. https://doi.org/10.1002/path.6394

Vancouver

Rätze MA, Enserink LN, Ishiyama N, van Kempen S, Veltman CH, Nijman IJ, et al. Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage. The Journal of Pathology. 2025. doi:10.1002/path.6394

BibTeX
@article{Rtze2025,
  author = {Rätze, Max Ak and Enserink, Lotte Nfl and Ishiyama, Noboru and van Kempen, Sven and Veltman, Christina Hj and Nijman, Isaac J and Haakma, Wisse E and Caldas, Carlos and Bernards, René and van Diest, Paul J and Christgen, Matthias and Koorman, Thijs and Derksen, Patrick Wb},
  title = {Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage},
  journal = {The Journal of Pathology},
  year = {2025},
  doi = {10.1002/path.6394}
}
Start for free →